This site is intended for healthcare professionals only

Delayed move to value-based pricing criticised

Written by: | Published:

Swift decision-making to enable a smooth transition to a system of value-based pricing for drugs used by the NHS must now be taken, the Health Select Committee has concluded, following its inquiry into NICE.

The committee was critical of the delay in setting out what a value-based pricing system for drugs entailed. Given that the government opened its consultation on the issue in December 2010, the committee said it was 'unacceptable' that the arrangements for value-based pricing had not been settled and that those who would have to work with those arrangements were still unclear about what the new drug-pricing regime would mean in practice.

What do you think? Leave a comment below or tweet your views to @IndyNurseMag

This material is protected by MA Healthcare Ltd copyright.
See Terms and Conditions.



Please view our Terms and Conditions before leaving a comment.

Change the CAPTCHA codeSpeak the CAPTCHA code

Most read articles from Practice Nursing Journal

Practice Nursing Journal latest issue and most read articles.

Click here to read a selection of free to access articles from Practice Nursing Journal


Sign up to the newsletter


Independent Nurse is the professional resource for primary care and community nurses, providing clinical articles for practice nurses and prescribers.


Subscribe to our newsletter and stay up to date with the latest nursing news.

Stay Connected

Stay social with Independent Nurse by following us on Twitter, liking us on Facebook or connecting on LinkedIn.


Need access to some of our older articles? You can view our archive, or alternatively contact us.

Contact Us

MA Healthcare Ltd.
St Jude's Church, Dulwich Road
London, SE24 0PB

Tel: +44 (0)20 7738 5454
Registered in England and Wales No. 01878373

Meet the team


Find out how to contribute to Independent Nurse here.